Health Care & Life Sciences » Pharmaceuticals | Jacobson Pharma Corp. Ltd.

Jacobson Pharma Corp. Ltd. | Balance Sheet

Fiscal year is April-March. All values HKD Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
131
70
83
360
657
630
Total Accounts Receivable
124
119
121
169
221
280
Inventories
160
169
197
261
316
334
Other Current Assets
29
35
99
44
48
-
Total Current Assets
445
394
500
834
1,242
1,244
Net Property, Plant & Equipment
468
664
867
1,057
1,030
1,058
Total Investments and Advances
-
-
-
-
209
761
Long-Term Note Receivable
-
-
-
-
13
-
Intangible Assets
373
423
427
1,057
1,087
1,073
Other Assets
168
221
27
20
26
118
Total Assets
1,457
1,705
1,822
2,970
3,611
4,261
ST Debt & Current Portion LT Debt
301
478
440
938
1,351
Accounts Payable
30
25
26
41
35
Income Tax Payable
9
3
11
13
5
Other Current Liabilities
150
145
339
67
70
Total Current Liabilities
489
650
817
1,058
1,461
Long-Term Debt
-
7
1
1
1
Deferred Taxes
41
44
47
136
137
Total Liabilities
540
699
866
1,198
1,603
Common Equity (Total)
878
957
907
1,749
1,976
Total Shareholders' Equity
878
957
907
1,749
1,976
Total Equity
917
1,007
956
1,772
2,008
Liabilities & Shareholders' Equity
1,457
1,705
1,822
2,970
3,611
Accumulated Minority Interest
39
49
49
23
32

About Jacobson Pharma Corp.

View Profile
Address
Unit 2313-18, 23/F
Hong Kong
Hong Kong
Employees -
Website http://www.jacobsonpharma.com
Updated 07/08/2019
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. It operates through the following segments: Generic Drugs, Proprietary Medicines, and Wholesale and Retal. The Generic Drugs segment develops, manufactures and distributes a host of off-patent medicines for various therapeutic use.